Insulet | PODD - Dochód Netto

Cena Akcji
218.10
Dzienna Zmiana
2.10 0.97%
Miesięcznie
-11.56%
Rocznie
-16.20%
Q1 Prognozy TE
209.52




Dochód Netto Zmiana Data
Abbott USD 1.78B 132M 2025-12
Align Technology USD 135.76M 79.01M 2025-12
AtriCure USD 1.76M 2.02M 2025-12
Avanos Medical USD -1.3M 100K 2025-12
Baxter International USD -1.13B 1.08B 2025-12
Becton, Dickinson and Co. USD 382M 111M 2025-12
Boston Scientific USD 672M 83M 2025-12
Cardinal Health USD 467M 17M 2025-12
Cooper Companies USD 130.8M 46.2M 2025-12
Dexcom USD 267.3M 16.5M 2025-12
Edwards Lifesciences USD 91.2M 199.9M 2025-12
Eli Lilly USD 6.64B 1.05B 2025-12
Globus Medical USD 140.59M 21.63M 2025-12
ICU Medical USD -15.73M 12.34M 2025-12
Inogen USD -5.96M 373K 2024-09
Insulet USD 101.6M 14M 2025-12
Integra LifeSciences USD -1.7M 3.7M 2025-12
J&J USD 5.12B 36M 2025-12
Masimo USD 68.3M 168.7M 2025-12
Medtronic USD 1.14B 231M 2025-12
Merit Medical Systems USD 27.76M 4.83M 2025-09
Roche Holding CHF 5.47B 1.76B 2025-12
Solventum Corp USD 63M 1.2B 2025-12
Stryker USD 849M 10M 2025-12
Tandem Diabetes Care USD -589K 20.58M 2025-12
Teleflex USD -714.33M 305.44M 2025-12
West Pharmaceutical Services USD 132.1M 7.9M 2025-12
Zimmer Biomet Holdings USD 139.3M 91.6M 2025-12